I-Ming Lee

Title: I-Ming Lee: Innovator in Glycoconjugate Vaccines

Introduction

I-Ming Lee is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of vaccine development, particularly in the area of glycoconjugate vaccines. His innovative work aims to provide protection against bacterial infections caused by Gram-negative pathogens.

Latest Patents

I-Ming Lee holds a patent for "Glycoconjugate vaccines, preparation method and uses thereof." This patent discloses a glycoconjugate vaccine that confers protection against Gram-negative pathogen infections. The patent also details a method for manufacturing the glycoconjugate vaccine and its use in treating bacterial infections. The structure of the glycoconjugate vaccine includes a maleimide-type linker connected to a carrier protein via a maleimide bond. The variables n and m in the formula can independently be integral or non-integral numbers ranging from 2 to 20. He has 1 patent to his name.

Career Highlights

I-Ming Lee is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at Academia Sinica has allowed him to focus on innovative research in vaccine technology, contributing to advancements in public health.

Collaborations

I-Ming Lee has collaborated with notable colleagues, including Shih-Hsiung Wu and Chung-Yi Wu. These collaborations have further enriched his research and development efforts in the field of glycoconjugate vaccines.

Conclusion

I-Ming Lee's contributions to glycoconjugate vaccine development highlight his role as an important inventor in the field of immunology. His innovative approaches and collaborations continue to pave the way for advancements in vaccine technology.